Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 26, 2024 16:05 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
November 12, 2024 16:12 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
November 07, 2024 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

NEW HOPE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
August 12, 2024 16:20 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
July 30, 2024 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

John Mack brings over 30 years of diverse medical device and healthcare technology experience to the Orchestra BioMed Board of Directors Most recently, Mr. Mack served as Medtronic’s President of...
June 04, 2024 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

NEW HOPE, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
May 22, 2024 08:43 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

NEW HOPE, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...
May 13, 2024 16:58 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

Company hosting in-person R&D day event, focused on atrioventricular interval modulation (“AVIM”) therapy, including the unmet need in hypertension, mechanism of action, clinical results and...
April 30, 2024 08:30 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Patent estate covering atrioventricular interval modulation (“AVIM”) therapy includes 37 issued U.S. patents and 73 patents outside the U.S. that collectively comprise over 1,800 claims related to the...
April 30, 2024 08:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

NEW HOPE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to...